Mr. D.S. Brar graduated with a Bachelor of Engineering (Electrical) degree from Thapar Institute of Engineering & Technology, Patiala. He further completed his Masters Degree in Business Administration with top rank (Gold Medal) from the Faculty of Management Studies, University of Delhi. After having started his career in 1974 with The Associated Cement Companies Limited (ACC), Mr. Brar has been associated with the Pharmaceutical Industry for three decades. Mr. Brar spent major part of this period (1977 - 2004) with Ranbaxy Laboratories Limited - India's largest Pharmaceutical company at various positions and rose to the level of President in 1993. He became the CEO & Managing Director of Ranbaxy in 1999. Mr. Brar stepped down from this position in 2004 to start his entrepreneurial journey and ventured into GVK Biosciences - a leading contract research organization providing Discovery & Development services to Global Life Sciences companies. Mr. Brar also promoted Davix Management Services - Pharmaceuticals focused Consulting/Advisory services company.

Mr. Brar currently holds Board positions in various Indian and International companies like MphasiS Limited - a subsidiary of EDS, Maruti Suzuki India Limited and Moksha8. He is also Special Advisor to the Board of Directors of Codexis Inc. and Adamas Pharmaceuticals Inc. From 2000 - 2007, Mr. Brar served as a Director of Reserve Bank of India (RBI) and was also a Member of the Inspection and Audit Sub-Committee of the Central Board of Directors of the RBI.

Mr. Brar has been involved with some of the premier Research and Educational institutions in India. He has served as a Member on the Board of National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar and is presently Chairman of Biotechnology Business Group of Punjab Biotechnology Incubator. Mr. Brar is also a Member of the Board of Governors of Indian Institute of Management, Lucknow (IIML).

Mr. Brar has been involved with several leading industry associations in India. He is a member of the National Council of the Confederation of Indian Industry (CII) and Chairman of CII's Indian MNC Council. He has served as a member of the Executive Committee of Federation of Indian Chambers of Commerce and Industry (FICCI) in the past. Mr. Brar was a Member of Prime Minister's Task Force on pharmaceuticals and knowledge-based industries which drafted the blue print for the growth and global expansion of Indian Pharmaceutical Industry including R&D and Pricing policies. For his service and contribution to the pharmaceutical industry, Mr. Brar was honoured with the Dean's Medal from the Tufts University School of Medicine, U.S.A. in 2004.